Increased kidney disease mortality among people with AIDS versus the general population: a population-based cohort study in Italy, 2006-2018.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
01 12 2022
Historique:
entrez: 1 12 2022
pubmed: 2 12 2022
medline: 6 12 2022
Statut: epublish

Résumé

This study aimed to assess whether an excess mortality related to kidney and other urinary tract diseases exists among Italian people with AIDS (PWA), as compared with the general population without AIDS (non-PWA). Population-based, retrospective cohort study. We conducted a nationwide study including 9481 Italian PWA, aged 15-74 years, reported to the National AIDS Registry between 2006 and 2018. Vital status and causes of death were retrieved by record linkage with the National Register of Causes of Death up to 2018. Excess mortality for PWA versus non-PWA was estimated through sex-standardised and age-standardised mortality ratios (SMRs) with corresponding 95% CIs. Among 2613 deceased PWA, 262 (10.0%) reported at least one urinary tract disease at death, including 254 (9.7%) non-cancer diseases-mostly renal failures (225 cases, 8.6%)-and 9 cancers (0.3%). The overall SMR for non-cancer urinary tract diseases was 15.3 (95% CI 13.4 to 17.3) with statistically significant SMRs for acute (SMR=22.3, 95% CI 18.0 to 27.4), chronic (SMR=8.4, 95% CI 6.0 to 11.3), and unspecified renal failure (SMR=13.8, 95% CI 11.2 to 16.8). No statistically significant excess mortality was detected for urinary tract cancers (SMR=1.7, 95% CI 0.8 to 3.3). The SMRs were particularly elevated among PWA aged <50 years, injecting drug users, or those with the first HIV-positive test >6 months before AIDS diagnosis. The excess mortality related to non-cancer kidney and other urinary tract diseases reported among PWA highlights the importance of implementing the recommendation for screening, diagnosis and management of such conditions among this population.

Identifiants

pubmed: 36456002
pii: bmjopen-2022-064970
doi: 10.1136/bmjopen-2022-064970
pmc: PMC9716863
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e064970

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMJ Open. 2019 May 5;9(5):e029211
pubmed: 31061062
BMC Infect Dis. 2018 Aug 28;18(1):428
pubmed: 30153797
Lancet. 1993 Feb 13;341(8842):441
pubmed: 8094208
Cancer Epidemiol Biomarkers Prev. 2021 Mar;30(3):554-563
pubmed: 33310788
Popul Health Metr. 2017 May 18;15(1):19
pubmed: 28521797
J Int AIDS Soc. 2018 Jan;21(1):
pubmed: 29334197
Lancet Oncol. 2021 Jun;22(6):e240-e253
pubmed: 34087151
HIV Med. 2020 Nov;21(10):642-649
pubmed: 32876382
Eur Rev Med Pharmacol Sci. 2013 Oct;17(19):2660-7
pubmed: 24142615
Clin Infect Dis. 2021 May 4;72(9):e224-e231
pubmed: 32710777
Lancet. 2014 Jul 19;384(9939):241-8
pubmed: 25042234
J Natl Cancer Inst. 2005 Mar 16;97(6):425-32
pubmed: 15770006
J Biomed Inform. 2001 Dec;34(6):387-95
pubmed: 12198758
Curr Opin HIV AIDS. 2021 Nov 1;16(6):303-308
pubmed: 34459469
BMC Infect Dis. 2015 Jun 12;15:229
pubmed: 26067992
Kidney Int. 2018 Mar;93(3):545-559
pubmed: 29398134
Clin Infect Dis. 2010 May 15;50(10):1387-96
pubmed: 20380565
PLoS One. 2015 Jun 17;10(6):e0129550
pubmed: 26083524
AIDS. 2015 Jun 1;29(9):1061-6
pubmed: 26125139
Open AIDS J. 2015 Feb 27;9:14-22
pubmed: 25767634
Kidney Int. 2014 Aug;86(2):259-65
pubmed: 24573317
Oncol Res Treat. 2017;40(3):106-112
pubmed: 28253510
Infection. 2012 Dec;40(6):627-34
pubmed: 22791407
AIDS Patient Care STDS. 2014 Oct;28(10):517-23
pubmed: 25275657
AIDS Res Ther. 2020 Mar 16;17(1):11
pubmed: 32178687
Lancet Public Health. 2017 Jan;2(1):e35-e46
pubmed: 29249478
N Engl J Med. 2017 Dec 14;377(24):2363-2374
pubmed: 29236630
Clin Kidney J. 2016 Dec;9(6):772-781
pubmed: 27994853
AIDS. 2014 Jan 14;28(2):257-65
pubmed: 24105030
J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):190-6
pubmed: 27116048

Auteurs

Martina Taborelli (M)

Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy mtaborelli@cro.it.

Barbara Suligoi (B)

Centro Operativo AIDS, Istituto Superiore di Sanità, Roma, Italy.

Diego Serraino (D)

Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

Luisa Frova (L)

Integrated system for health, social assistance and welfare, Istituto Nazionale di Statistica, Rome, Italy.

Enrico Grande (E)

Integrated system for health, social assistance and welfare, Istituto Nazionale di Statistica, Rome, Italy.

Federica Toffolutti (F)

Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

Vincenza Regine (V)

Centro Operativo AIDS, Istituto Superiore di Sanità, Roma, Italy.

Marilena Pappagallo (M)

Integrated system for health, social assistance and welfare, Istituto Nazionale di Statistica, Rome, Italy.

Lucia Pugliese (L)

Centro Operativo AIDS, Istituto Superiore di Sanità, Roma, Italy.

Francesco Grippo (F)

Integrated system for health, social assistance and welfare, Istituto Nazionale di Statistica, Rome, Italy.

Antonella Zucchetto (A)

Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH